SCIEX focus on Drug Quality
How pure are your biopharmaceuticals? SCIEX testing solutions will show you.
Drug product quality has a big impact on its ability to help treat conditions and cure diseases. The growing expansion of biopharmaceutical development challenges analytical scientists to develop quicker and more accurate methods to test drug quality. The shift towards more cell and gene therapies and mRNA-based pharmaceuticals has further challenged scientists to develop testing methods.
Overcoming these challenges is crucial to speed up drug development and production. SCIEX offers comprehensive support and expertise in developing testing methods for not only the classical protein biotherapeutics but also this next generation of mRNA and gene therapy drugs.
Here is some exclusive content we’ve put together for you.
Cell and gene therapy compendium: new edition 2024
Access this biopharmaceutical collection as the one stop shop for all your development of next-generation gene therapies and vaccines needs and questions.
DownloadIn-depth characterization of monoclonal antibodies and antibody-drug conjugates (tech note)
This technical note highlights the power of native mass spectrometry (MS) and electron activated dissociation (EAD).
DownloadA new approach for high resolution full and empty AAV capsid analysis (tech note)
This tech note highlights the power of CE to analyze viral vector samples.
DownloadBioPhase 8800 system (brochure)
A multi-capillary electrophoresis system that enables biopharma scientists to run multiple samples in parallel, accelerating the development and execution of sensitive, high-throughput analytical methods for CGT, mRNA and protein biotherapeutics.
DownloadZenoTOF 7600 system (brochure)
A high-resolution mass spectrometry solution that combines powerful MS/MS sensitivity, fragmentation technology and a step-change in biopharmaceutical characterization.
Download